![Philip Jull](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philip Jull
Directeur Général chez
RIZE ONCOLOGY INC.
Fortune : 2 M $ au 31/05/2026
Profil
Philip Gage Jull was the founder of Bordeaux Capital, Inc., founded in 2015, where the title held was Chairman from 2015 to 2022.
Current jobs include Chief Executive Officer & Director at Rize Oncology, Inc. starting in 2025; Executive Chairman at Arrow Exploration Corp.
since 2020; Executive Chairman at Euromax Resources Ltd. starting in 2026; Director at GeneTether, Inc.; and Non-Executive Director at Entropy Neurodynamics Ltd. since 2020.
Former jobs include Managing Director-Corporate Finance at Research Capital Corp.
from 2004 to 2015; Independent Director at Aldridge Minerals, Inc.; and Independent Director at Tryp Therapeutics, Inc. from 2020 to 2024.
Education includes undergraduate studies at the University of Toronto and an MBA from the University of Western Ontario.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARROW EXPLORATION CORP. 2,54 % | 23/03/2026 | 7 248 508 ( 2,54 % ) | 2 M $ | 31/05/2026 |
RIZE ONCOLOGY INC. 0,2 % | 10/11/2025 | 148 919 ( 0,2 % ) | 2 155 $ | 30/04/2025 |
| 02/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Philip Jull
| Sociétés | Poste | Début |
|---|---|---|
| ARROW EXPLORATION CORP. | Président | 21/03/2020 |
| RIZE ONCOLOGY INC. | Directeur Général | 16/10/2025 |
| EUROMAX RESOURCES LTD. | Président | 05/01/2026 |
GeneTether, Inc.
 GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services Develops gene editing technologies intended for human therapeutic applications | Directeur/Membre du Conseil | - |
Anciens postes connus de Philip Jull
| Sociétés | Poste | Fin |
|---|---|---|
Tryp Therapeutics, Inc.
 Tryp Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Président | 01/05/2024 |
Bordeaux Capital, Inc.
 Bordeaux Capital, Inc. Investment ManagersFinance Provides investment advisory services | Fondateur | 01/01/2022 |
Research Capital Corp.
 Research Capital Corp. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/11/2015 |
| ALDRIDGE MINERALS INC. | Directeur/Membre du Conseil | - |
Formation de Philip Jull
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Euromax Resources Ltd.
 Euromax Resources Ltd. Precious MetalsNon-Energy Minerals Engages in the identification, acquisition and development of mineral resources | Non-Energy Minerals |
Aldridge Minerals, Inc.
 Aldridge Minerals, Inc. Precious MetalsNon-Energy Minerals Explores and mines for gold, copper, lead and zinc concentrates | Non-Energy Minerals |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Western Ontario
 University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Research Capital Corp.
Research Capital Corp. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Bordeaux Capital, Inc.
Bordeaux Capital, Inc. Investment ManagersFinance Provides investment advisory services | Finance |
Arrow Exploration Corp.
 Arrow Exploration Corp. Oil & Gas ProductionEnergy Minerals Produces and explores oil and natural gas | Energy Minerals |
Tryp Therapeutics, Inc.
Tryp Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
GeneTether, Inc.
GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services Develops gene editing technologies intended for human therapeutic applications | Commercial Services |
GeneTether Therapeutics, Inc.
 GeneTether Therapeutics, Inc. BiotechnologyHealth Technology Develops gene editing therapies and platform | Health Technology |
